Overexpression of APP appears to be a key component in developing Alzheimer's disease in people with DS. Within the context of the reported findings discussed above, pharmacological therapies such as Donepezil and Memantine may have a role in the management of dementia; however, research with more persons with DS is needed. The gene discussed is APP; the disease is Dravet syndrome.